Carta al Director
Experiencia con inhibidores PCSK9 desde una consulta de Nefrología
Experience with PCSK9 inhibitors from a Nephrology unit
Verónica Escudero Quesada
, Jonay Pantoja Pérez, Cristina Castro Alonso, July Vanessa Osma Capera, Alejandro Valero Antón, Asunción Sancho Calabuig
Corresponding author
Servicio de Nefrología, Hospital Universitario Dr. Peset, Valencia, España
Read
5627
Timeswas read the article
2091
Total PDF
3536
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 69 | 49 | 118 |
| 2025 10 | 80 | 61 | 141 |
| 2025 9 | 91 | 55 | 146 |
| 2025 8 | 87 | 66 | 153 |
| 2025 7 | 76 | 48 | 124 |
| 2025 6 | 152 | 132 | 284 |
| 2025 5 | 108 | 46 | 154 |
| 2025 4 | 65 | 34 | 99 |
| 2025 3 | 124 | 84 | 208 |
| 2025 2 | 110 | 44 | 154 |
| 2025 1 | 88 | 50 | 138 |
| 2024 12 | 69 | 63 | 132 |
| 2024 11 | 55 | 94 | 149 |
| 2024 10 | 58 | 48 | 106 |
| 2024 9 | 78 | 47 | 125 |
| 2024 8 | 80 | 64 | 144 |
| 2024 7 | 65 | 37 | 102 |
| 2024 6 | 77 | 60 | 137 |
| 2024 5 | 94 | 56 | 150 |
| 2024 4 | 99 | 54 | 153 |
| 2024 3 | 91 | 33 | 124 |
| 2024 2 | 93 | 59 | 152 |
| 2024 1 | 74 | 41 | 115 |
| 2023 12 | 60 | 28 | 88 |
| 2023 11 | 67 | 32 | 99 |
| 2023 10 | 103 | 32 | 135 |
| 2023 9 | 142 | 37 | 179 |
| 2023 8 | 94 | 32 | 126 |
| 2023 7 | 57 | 39 | 96 |
| 2023 6 | 53 | 24 | 77 |
| 2023 5 | 78 | 48 | 126 |
| 2023 4 | 43 | 23 | 66 |
| 2023 3 | 74 | 31 | 105 |
| 2023 2 | 57 | 23 | 80 |
| 2023 1 | 51 | 27 | 78 |
| 2022 12 | 117 | 36 | 153 |
| 2022 11 | 113 | 38 | 151 |
| 2022 10 | 99 | 42 | 141 |
| 2022 9 | 64 | 46 | 110 |
| 2022 8 | 60 | 45 | 105 |
| 2022 7 | 94 | 67 | 161 |
| 2022 6 | 120 | 95 | 215 |
| 2022 5 | 7 | 21 | 28 |
Show all
